News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Trump and Putin held an 85-minute call on Ukraine, Iran, and NATO logistics, adding geopolitical risk ahead of the Ankara NATO summit.
  • Australia formalized a security partnership with Fiji and a uranium export deal with India, strengthening regional defense and energy links.
  • Investors rotated into Indian equities amid AI-led rally strains, favoring calmer trading and improving macro fundamentals.
  • WhiteFiber (WYFI), a small-cap AI colo operator, pulled back into the low $30s and trades as a leveraged play on AI power capacity.
  • New Zealand's National Party pledged seven new free-trade talks within five years, signaling a pro-trade economic agenda if elected.

Latest Articles

Nexalin Technology Announces that the Investigator of Its Brazilian Clinical Trial Received the Young Researcher Award at BRAIN 2026 for Research Evaluating the Company’s Proprietary DIFS™ Platform

Nexalin Technology Announces that the Investigator of Its Brazilian Clinical Trial Received the Young Researcher Award at BRAIN 2026 for Research Evaluating the Company’s Proprietary DIFS™ Platform

Nexalin Technology announced that Dr. Victor Fontenelle Bastos de Lima, an investigator on its recent Brazilian clinical trial, received the Young Researcher Award at the BRAIN 2026 Congress for evaluating Nexalin's proprietary Deep Intracranial Frequency Stimulation (DIFS™) platform. The award-winning research demonstrated significant and durable …

Moderna’s Rebound: A Swing Trade to Ride the Approval Wave

Moderna’s Rebound: A Swing Trade to Ride the Approval Wave

Moderna is staging a comeback after a strong run this year. With an FDA decision on its mRNA influenza candidate due 08/05/2026, solid clinical progress across multiple programs, $7.5B in cash and improving technicals, the stock looks set for another leg higher. This trade idea lays out an actionable swing entry, stop and target with rationale and …

Korean leveraged ETF approvals touch off global memory chip rout

Korean leveraged ETF approvals touch off global memory chip rout

A recent decision by South Korean regulators to allow high-leverage, single-stock ETFs tied to Samsung Electronics and SK Hynix has triggered a severe selloff in memory chip shares across Asian markets and pressured US futures. Regulators publicly expressed regret for greenlighting the products, which ballooned to sizable retail-dominated holdings …

LM Funding America Announces Strategic Expansion into High-Performance Computing and AI Infrastructure

LM Funding America Announces Strategic Expansion into High-Performance Computing and AI Infrastructure

LM Funding America, a Nasdaq-listed Bitcoin treasury and mining company, announced a strategic expansion into high-performance computing (HPC) and artificial intelligence (AI) infrastructure. Leveraging its 26 megawatts of wholly-owned low-cost power infrastructure across Oklahoma and Mississippi, the company has ordered initial AI GPU server hardw…

Silo Pharma Reports Positive Stability Data for SPC-15 PTSD Treatment, Advancing Program Toward First-in-Human Clinical Trial

Silo Pharma Reports Positive Stability Data for SPC-15 PTSD Treatment, Advancing Program Toward First-in-Human Clinical Trial

Silo Pharma announced positive stability data for SPC-15, their investigational intranasal treatment for PTSD, confirming its physical, chemical, and microbiological stability over nine months. This milestone supports the advancement of the FDA IND-enabling program and prepares the company for a first-in-human Phase 1 clinical trial, emphasizing ad…

Meloni Weighs Early April Election as Support Ebbs, Budget Timing a Concern

Meloni Weighs Early April Election as Support Ebbs, Budget Timing a Concern

Italian Prime Minister Giorgia Meloni is reportedly considering calling a general election as soon as April, several years ahead of the statutory deadline at the end of 2027. Sources say Meloni fears further erosion of her approval ratings if she postpones the vote. An election in late 2027 would compress the timeline for a successor government to …

Alpha Cash Comes Home: North Carolina Approval Takes Seven-State Footprint Past 3 Million Unbanked Households

Alpha Cash Comes Home: North Carolina Approval Takes Seven-State Footprint Past 3 Million Unbanked Households

Alpha Modus Holdings, Inc. announced that its financial services subsidiary, Alpha Modus Financial Services, LLC, received regulatory approval to operate in North Carolina as an authorized delegate for Barri Money Services. This approval allows Alpha Cash to offer check deposit and remittance services via kiosks and a mobile app to North Carolina r…

Micron to $1,600: Buy the Post-Earnings AI Repricing

Micron to $1,600: Buy the Post-Earnings AI Repricing

Micron's core memory business sits squarely in the bottleneck layer of the AI infrastructure buildout. With a $1.36T market cap, double-digit ROE, and a multi-year supply agreement with Anthropic, the stock can re-rate to $1,600 after a strong report on 06/24/2026. This trade plan gives a concrete entry, stop and target, with clear horizon and risk…

Safe Pro Awarded New $1.3 Million U.S. Army Subcontract to Integrate Real-Time AI Landmine Detection into Unmanned Ground Vehicles

Safe Pro Awarded New $1.3 Million U.S. Army Subcontract to Integrate Real-Time AI Landmine Detection into Unmanned Ground Vehicles

Safe Pro Group Inc., a Nasdaq-listed AI defense technology company, announced it has secured a $1.3 million subcontract from the U.S. Army to integrate its AI-based real-time explosive threat detection technology into autonomous unmanned ground vehicles (UGVs). This contract, awarded through a major U.S. defense prime contractor, will enable Safe P…

Alps Group Inc Launches Patient-Derived Organoid Program to Advance Personalized Cancer Care in Southeast Asia

Alps Group Inc Launches Patient-Derived Organoid Program to Advance Personalized Cancer Care in Southeast Asia

Alps Group Inc, a Nasdaq-listed biotechnology platform headquartered in Malaysia, announced its entry into patient-derived organoid technology through a collaboration with Dr. Kong Wai Mun. The new program aims to develop Malaysia's first clinically validated PDO platform to advance personalized cancer care and preclinical drug screening. This init…